HHS: Medication Assisted Treatment for Opioid Use Disorders; Correction

July 6, 2017

Correction made to afinal rule that appeared in the Federal Register on July 8, 2016 regarding increased access to treatment with buprenorphine and buprenorphine/naloxone. HHS mistakenly listed the American Osteopathic Academy of Addiction Medicine (AOAAM) as an approved credentialing organization when they intended to reference the American Osteopathic Association (AOA). (Source: Federal Register updates via […]

Read the full article →

Physician efforts to reverse opioid epidemic quantified

July 6, 2017

When patients present with issues, physicians look to the most effective tools for treatment. The same is true in addressing an epidemic. While much more work remains to reverse the nation ’s opioid epidemic, using tools such as prescription drug monitoring programs (PDMP), medication-assisted treatment and naloxone, physicians are making progress. A new fact sheet […]

Read the full article →

Dependence on over the counter (OTC) codeine containing analgesics: treatment and recovery with buprenorphine naloxone – Hout MCV, Delargy I, Ryan G, Flanagan S, Gallagher H.

July 6, 2017

We present a clinical case series of four adult patients dependent on OTC codeine combination analgesics in Ireland. Cases (… (Source: SafetyLit) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg

July 6, 2017

PHILADELPHIA, Sept. 20, 2016 — (Healthcare Sales & Marketing Network) — Lannett Company, Inc. (LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Buprenorphi… Biopharmaceuticals, Generics, FDA Lannett, Buprenorphine, Naloxone (Source: HSMN NewsFeed)

Read the full article →

Suboxone maker sued by U.S. states alleging anticompetitive practices

July 6, 2017

35 U.S. states and District of Columbia file an antitrust lawsuit alleging that British drugmaker Indivior tried to keep cheaper, generic versions of Suboxone off the market. (Source: CBC | Health)

Read the full article →

States sue Suboxone drugmaker

July 6, 2017

A lawsuit filed by 35 states and the District of Columbia alleges that drugmaker Indivior violated antitrust laws by trying to extend its monopoly over Suboxone, New York’s attorney general announced Thursday. Suboxone is a prescription drug used to treat patients addicted to heroin, painkillers and other opioid drugs. (Source: CNN.com – Health)

Read the full article →

35 States File'Product Hopping' Lawsuit Against Indivior

July 6, 2017

British opiod drugmaker Indivior is facing lawsuits from 35 U.S. states alleging it employed a product hopping strategy to keep generic versions of Suboxone off the market. (Source: PharmaManufacturing.com)

Read the full article →

Canadian Doctors Can Now Prescribe Heroin

July 6, 2017

Canadian doctors can now prescribe heroin to people with serious addictions to the drug. This change is thanks to new regulations approved earlier this month by the Canadian government. The government says this treatment will be limited to a small number of users “in cases where traditional options have been tried and proven ineffective.” Doctors […]

Read the full article →

U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)

July 6, 2017

MORRISTOWN, N.J., Oct. 6, 2016 — (Healthcare Sales & Marketing Network) — Orexo US announced today that the U.S. Food and Drug Administration (FDA) has approved ZUBSOLV® (buprenorphine/naloxone CIII sublingual tablet) 0.7mg/0.18mg for the treatment … Biopharmaceuticals, FDA Orexo, ZUBSOLV, buprenorphine, naloxone (Source: HSMN NewsFeed)

Read the full article →

Houston Concierge Medicine Now Offering Outpatient Drug Rehab…

July 6, 2017

Houston Concierge Medicine and Wellness is now offering outpatient drug rehab therapy with Suboxone. The therapy is highly effective for helping patients who want to get off of opiates as an…(PRWeb November 03, 2016)Read the full story at http://www.prweb.com/releases/suboxonedoctorshouston/outpatientdrugrehab/prweb13821692.htm (Source: PRWeb: Medical Pharmaceuticals)

Read the full article →